Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in spain, A retrospective cohort study

  • Román, Marta|||0000-0001-9076-8918
  • Rué, Montserrat|||0000-0002-7862-9365
  • Sala, Maria|||0000-0002-9955-8746
  • Ascunce, Nieves
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Baroja, Araceli
  • la Vega Prieto, Mariola de|||0000-0003-3094-7898
  • Galceran, Jaume|||0000-0002-1584-7293
  • Natal, Carmen|||0000-0003-0204-3947
  • Salas, Dolores|||0000-0003-0064-1222
  • Sánchez Jacob, Mercedes
  • Zubizarreta Alberdi, Raquel
  • Castells, Xavier|||0000-0002-2528-0382
  • Blanch, Jordi|||0000-0003-2597-8454
  • Romero, Anabel
  • Almazán, Raquel
  • Fernández, Ana Belén
  • Queiro, María Teresa
  • Delfrade, Iosu
  • Ederra, María
  • Erdozain, Nieves
  • Vidán, Juana
  • Ibáñez, Josefa
  • Cuevas, Dolores
  • la Lastra, Isabel Díez de
  • González Román, Isabel
Background: Breast cancer incidence has decreased in the last decade, while the incidence of ductal carcinoma in situ (DCIS) has increased substantially in the western world. The phenomenon has been attributed to the widespread adaption of screening mammography. The aim of the study was to evaluate the temporal trends in the rates of screen detected invasive cancers and DCIS, and to compare the observed trends with respect to hormone replacement therapy (HRT) use along the same study period. Methods: Retrospective cohort study of 1,564,080 women aged 45-69 years who underwent 4,705,681 screening mammograms from 1992 to 2006. Age-adjusted rates of screen detected invasive cancer, DCIS, and HRT use were calculated for first and subsequent screenings. Poisson regression was used to evaluate the existence of a change-point in trend, and to estimate the adjusted trends in screen detected invasive breast cancer and DCIS over the study period. Results: The rates of screen detected invasive cancer per 100.000 screened women were 394.0 at first screening, and 229.9 at subsequent screen. The rates of screen detected DCIS per 100.000 screened women were 66.8 at first screen and 43.9 at subsequent screens. No evidence of a change point in trend in the rates of DCIS and invasive cancers over the study period were found. Screen detected DCIS increased at a steady 2.5% per year (95% CI: 1.3; 3.8), while invasive cancers were stable. Conclusion: Despite the observed decrease in breast cancer incidence in the population, the rates of screen detected invasive cancer remained stable during the study period. The proportion of DCIS among screen detected breast malignancies increased from 13% to 17% throughout the study period. The rates of screen detected invasive cancer and DCIS were independent of the decreasing trend in HRT use observed among screened women after 2002.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Factors associated with readmissions in women participating in screening programs and treated for breast cancer, A retrospective cohort study

  • Miret, Carme|||0000-0001-6154-3998
  • Domingo, Laia|||0000-0003-4420-0891
  • Louro, Javier|||0000-0002-2985-3301
  • Barata, Teresa
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Ferrer, Joana
  • Carmona-Garcia, M. Carmen|||0000-0002-4011-9474
  • Castells, Xavier|||0000-0002-2528-0382
  • Sala, Maria|||0000-0002-9955-8746
Background: We aimed to identify the risk factors associated with early, late and long-term readmissions in women diagnosed with breast cancer participating in screening programs. Methods: We performed a multicenter cohort study of 1055 women aged 50-69 years participating in Spanish screening programs, diagnosed with breast cancer between 2000 and 2009, and followed up to 2014. Readmission was defined as a hospital admission related to the disease and/or treatment complications, and was classified as early (< 30 days), late (30 days-1 year), or long-term readmission (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes

  • Domingo, Laia|||0000-0003-4420-0891
  • Sala, Maria|||0000-0002-9955-8746
  • Louro, Javier|||0000-0002-2985-3301
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Barata, Teresa
  • Ferrer, Joana
  • Carmona-Garcia, M. Carmen|||0000-0002-4011-9474
  • Comas Serrano, Mercè|||0000-0003-1926-2740
  • Castells, Xavier|||0000-0002-2528-0382
Background. Our aim was to assess the role of breast density on breast cancer mortality and recurrences, considering patient and tumour characteristics and the treatments received among women attending population-based screening programmes. Methods. We conducted a retrospective cohort study among women aged 50-69 years attending population-based screening programmes, diagnosed with invasive breast cancer between 2000 and 2009, and followed up to 2014. Breast density was categorised as low density (≤25% dense tissue), intermediate density (25-50%), and high density (≥50%). Cox proportional hazards regression models were fitted to estimate the adjusted hazard ratios (aHR) and 95% confidence intervals (95% CI) for death and recurrences, adjusting by patient characteristics, mode of detection (screen-detected vs. interval cancer), and tumour features. Results. The percentage of deaths and recurrences was higher among women with intermediate- and high-density breasts than among women with low-density breasts (p=0.011 for death; p=0.037 for recurrences). Adjusted Cox proportional hazards regression models revealed that women with intermediate- and high-density breasts had a higher risk of death than women with low-density breasts, being statistically significant for intermediate densities (aHR = 2.19 [95% CI: 1.16-4.13], aHR = 1.44 [95% CI: 0.67-3.1], respectively). No association was found between breast density and recurrences. Conclusions. Breast density was associated with a higher risk of death, but not of recurrences, among women participating in breast cancer screening. These findings reinforce the need to improve screening sensitivity among women with dense breasts and to routinely assess breast density, not only for its role as a risk factor for breast cancer but also for its potential influence on cancer prognosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Readmissions and complications in breast ductal carcinoma in situ, A retrospective study comparing screen- and non-screen-detected patients

  • Politi, Julieta|||0000-0001-7315-034X
  • Sala, Maria|||0000-0002-9955-8746
  • Domingo, Laia|||0000-0003-4420-0891
  • Vernet-Tomas, Maria|||0000-0002-5575-2475
  • Román, Marta|||0000-0001-9076-8918
  • Macià Guilà, Francesc|||0000-0002-6090-5894
  • Castells, Xavier|||0000-0002-2528-0382
Population-wide mammographic screening programs aim to reduce breast cancer mortality. However, a broad view of the harms and benefits of these programs is necessary to favor informed decisions, especially in the earliest stages of the disease. Here, we compare the outcomes of patients diagnosed with breast ductal carcinoma in situ in participants and non-participants of a population-based mammographic screening program. A retrospective cohort study of all patients diagnosed with breast ductal carcinoma in situ between 2000 and 2010 within a single hospital. A total of 211 patients were included, and the median follow-up was 8.4 years. The effect of detection mode (screen-detected and non-screen-detected) on breast cancer recurrences, readmissions, and complications was evaluated through multivariate logistic regression analysis. In the majority of women, breast ductal carcinoma in situ was screen-detected (63.5%). Screen-detected breast ductal carcinoma in situ was smaller in size compared to those non-screen-detected (57.53% < 20 mm versus 78.03%, p = 0.002). Overall, breast-conserving surgery was the most frequent surgery (86.26%); however, mastectomy was higher in non-screen-detected breast ductal carcinoma in situ (20.78% versus 9.7%, p = 0.024). Readmissions for mastectomy were more frequent in non-screen-detected breast ductal carcinoma in situ. Psychological complications, such as fatigue, anxiety, and depression, had a prevalence of 15% within our cohort. Risk of readmissions and complications was higher within the non-screen-detected group, as evidenced by an odds ratio = 6.25 (95% confidence interval = 1.95-19.99) for readmissions and an odds ratio = 2.41 (95% confidence interval = 1.95-4.86) for complications. Our findings indicate that women with breast ductal carcinoma in situ breast cancer diagnosed through population-based breast cancer screening program experience a lower risk of readmissions and complications than those diagnosed outside these programs. These findings can help aid women and health professionals make informed decisions regarding screening.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Biomarkers expression in benign breast diseases and risk of subsequent breast cancer, a case-control study

  • Posso, Margarita|||0000-0002-5053-257X
  • Corominas, Josep
  • Serrano, Laia
  • Román, Marta|||0000-0001-9076-8918
  • Torá-Rocamora, Isabel|||0000-0002-5946-4569
  • Domingo, Laia|||0000-0003-4420-0891
  • Romero, Anabel
  • Quintana Ruiz, Maria Jesús|||0000-0002-1055-9786
  • Vernet-Tomas, Maria|||0000-0002-5575-2475
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Vidal, Carmen|||0000-0003-2768-2710
  • Sánchez Movellán, Mar
  • Saladié, Francina|||0000-0002-1783-4066
  • Natal, Carmen|||0000-0003-0204-3947
  • Ferrer, Joan
  • Servitja, Sonia|||0000-0001-6988-4519
  • Sala, Maria|||0000-0002-9955-8746
  • Castells, Xavier|||0000-0002-2528-0382
  • Buron, Andrea|||0000-0003-3590-1303
  • Rodríguez-Arana, A.
  • Romero, A.
  • Vernet, M.
  • Andreu, Xavier
  • Milà, N.
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Fernández-Somoano, A.
  • Galceran, Jaume|||0000-0002-1584-7293
  • Espinàs, J.A.
Women with benign breast diseases (BBD) have a high risk of breast cancer. However, no biomarkers have been clearly established to predict cancer in these women. Our aim was to explore whether estrogen receptor (ER), progesterone receptor (PR), and Ki67 expression stratify risk of breast cancer in screened women with BBD. We conducted a nested case-control study. Women with breast cancer and prior BBDs (86 cases) were matched to women with prior BBDs who were free from breast cancer (172 controls). The matching factors were age at BBD diagnosis, type of BBD, and follow-up time since BBD diagnosis. ER, PR, and Ki67 expression were obtained from BBDs' specimens. Conditional logistic regression was used to estimate odds ratios (ORs), and 95% confidence intervals (CIs) of breast cancer risk according to ER, PR, and Ki67 expression. Women with.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease, a study from a population-based screening program

  • Castells, Xavier|||0000-0002-2528-0382
  • Domingo, Laia|||0000-0003-4420-0891
  • Corominas Torres, Josep M.|||0000-0001-5049-7201
  • Torá-Rocamora, Isabel|||0000-0002-5946-4569
  • Quintana Ruiz, Maria Jesús|||0000-0002-1055-9786
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Vidal, Carmen|||0000-0003-2768-2710
  • Natal, Carmen|||0000-0003-0204-3947
  • Sánchez Movellán, Mar
  • Saladié, Francina|||0000-0002-1783-4066
  • Ferrer, Joana
  • Vernet-Tomas, Maria|||0000-0002-5575-2475
  • Servitja, Sonia|||0000-0001-6988-4519
  • Rodríguez Arana, Ana|||0000-0003-3115-0178
  • Roman, Marta
  • Espinàs, Josep Alfons
  • Sala, Maria|||0000-0002-9955-8746
Benign breast disease increases the risk of breast cancer. This association has scarcely been evaluated in the context of breast cancer screening programs although it is a prevalent finding in mammography screening. We assessed the association of distinct categories of benign breast disease and subsequent risk of breast cancer, as well as the influence of a family history of breast cancer. A retrospective cohort study was conducted in 545,171 women aged 50-69 years biennially screened for breast cancer in Spain. The median of follow-up was 6.1 years. The age-adjusted rate ratio (RR) of breast cancer for women with benign breast disease, histologically classified into nonproliferative and proliferative disease with and without atypia, compared with women without benign breast disease was estimated by Poisson regression analysis. A stratified analysis by family history of breast cancer was performed in a subsample. All tests were two-sided. The age-adjusted RR of breast cancer after diagnosis of benign breast disease was 2.51 (95 % CI: 2.14-2.93) compared with women without benign breast disease. The risk was higher in women with proliferative disease with atypia (RR = 4.56, 95 % CI: 2.06-10.07) followed by those with proliferative disease without atypia (RR = 3.58; 95 % CI = 2.61-4.91). Women with nonproliferative disease and without a family history of breast cancer remained also at increased risk of cancer (OR = 2.23, 95 % CI: 1.86-2.68). An increased risk of breast cancer was observed among screening participants with proliferative or nonproliferative benign breast disease, regardless of a family history of breast cancer. This information may be useful to explore risk-based screening strategies.